AstraZeneca moved to bolster its COVID-19 portfolio of antibodies on Tuesday with a $157 million licensing deal for experimental therapies developed by newly-launched biotech RQ Bio...
Takeda Pharma has expanded its innovative rare diseases portfolio in India with the launch of Adynovate, an innovative extended half-life recombinant Factor VIII (rFVIII) treatment, using established technology (controlled PEGylation)...
Drugmaker BDR Pharma has raised ₹685 crore from a consortium of investors led by private equity firm Multiples...
Regulatory bodies throughout the world seek to protect public health and ensure the safety, effectiveness, and security of pharmaceuticals, biologics, and medical devices in their respective territories.
Halesaga, a prominent health and wellness brand, has announced the launch of a new line of wellness goods with a 5 per cent discount on prepaid orders...
Biological E (BE) produced Corbevax vaccine shot for children has reduced the price of its COVID-19 vaccine, from Rs. 840 to Rs.250 a dose inclusive of GST,for private COVID-19 vaccination centres...
The Serum Institute of India (SII) has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer after the completion of the phase 2/3 clinical...
The Hyderabad-based CSIR-Centre for Cellular and Molecular Biology (CCMB) on Friday announced the development of a potential mRNA vaccine candidate against SARS-CoV-2, the virus which causes Covid-19. The Hyderabad-based CSIR-Centre for Cellular and
Zydus Lifesciences on Friday said it has launched in India its Bempedoic acid drug under the Bemdac brand for treatment of uncontrolled levels of bad cholesterol...
Sun Pharmaceutical Industries on Thursday said it has received final approval from the US health regulator for Mesalamine extended release capsules, used to treat bowel disease, in the American market...
, CDSCO.jpg)
